In right-sided CRCs (caecum to splenic flexure), we observed no prognostic impact of CDX2 expression in contrast to a retained high prognostic relevance of CRC subtypes, tumour budding and WHO grade comparable to the data from the overall cohort. The gene discussed is CDX2; the disease is colorectal carcinoma.